According to the Zhitong Finance APP, Sanxin Medtec (300453.SZ) announced that the company plans to invest USD 100,000 using its own funds to establish a wholly-owned subsidiary, Sanxin Medtec (Hong Kong) Limited, in Hong Kong (the final name will be subject to the registration results, referred to as "Hong Kong Sanxin"). The registered capital of Hong Kong Sanxin is USD 100,000, and the company holds 100% equity in it.

This external investment to establish a wholly-owned subsidiary in Hong Kong is an important measure for the company to implement its development strategy, which is conducive to strengthening the company's cooperation and communication with international markets and expanding overseas business. It has a positive impact on the company's long-term development and strategic layout, aligning with the company's development strategy